CompanyTrack

UCB CELLTECH

FC027218
Active Anderlecht
1,464 employees website.com
Life sciences and medical technology
U

UCB CELLTECH

FC027218
Founded 20 Dec 2006 Active Anderlecht, Belgium 1,464 employees website.com
Life sciences and medical technology

Previous Company Names

UCB PHARMA 29 Dec 2006 — 17 Jan 2007
Accounts Submitted 20 Aug 2025
Confirmation Not Submitted
Net assets £10,243M £317M 2023 year on year
Total assets £13,195M £294M 2023 year on year
Total Liabilities £2,952M £22M 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

60 Allée De La Recherche Anderlecht Anderlecht 1070 Belgium

Website

www.example.com

Full company profile for UCB CELLTECH (FC027218), an active life sciences and medical technology company based in Anderlecht, Belgium. Incorporated 20 Dec 2006. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type full
Next accounts 31 Dec 2025
Due by —

Balance Sheet & P&L (2014–2023)

Cash in Bank

£6.67M

Decreased by £8.24M (-55%)

Net Assets

£10242.87M

Increased by £316.70M (+3%)

Total Liabilities

£2951.69M

Decreased by £22.43M (-1%)

Turnover

£2758.31M

Decreased by £159.62M (-5%)

Employees

1464

Increased by 103 (+8%)

Debt Ratio

22%

Decreased by 1 (-4%)
See 10 Year Full Financials

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Ucb Pharma
NaN%

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Aug 2025AccountsAnnual accounts made up to 31 Dec 2024
14 Aug 2024AccountsAnnual accounts made up to 31 Dec 2023
13 Sept 2023OfficersTermination Person Authorised Overseas Company
13 Sept 2023OfficersTermination Person Authorised Overseas Company
29 Aug 2023OfficersTermination of Charl Van Zyl as director on 1 Jul 2023
20 Aug 2025 Accounts

Annual accounts made up to 31 Dec 2024

14 Aug 2024 Accounts

Annual accounts made up to 31 Dec 2023

13 Sept 2023 Officers

Termination Person Authorised Overseas Company

13 Sept 2023 Officers

Termination Person Authorised Overseas Company

29 Aug 2023 Officers

Termination of Charl Van Zyl as director on 1 Jul 2023

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

10 months ago on 20 Aug 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 14 Aug 2024

Termination Person Authorised Overseas Company

2 years ago on 13 Sept 2023

Termination Person Authorised Overseas Company

2 years ago on 13 Sept 2023

Termination of Charl Van Zyl as director on 1 Jul 2023

2 years ago on 29 Aug 2023